Анналы клинической и экспериментальной неврологии (Feb 2017)

Regulatory T-cells CD4+CD25+Foxр3+ in patients with remitting multiple sclerosis

  • D. D. Eliseeva,
  • I. A. Zavalishin,
  • S. N. Bykovskaya,
  • T. N. Fedorova,
  • E. N. Karandashov,
  • O. A. Trunova

DOI
https://doi.org/10.17816/psaic311
Journal volume & issue
Vol. 5, no. 2
pp. 9 – 13

Abstract

Read online

In the maintenance of immunological tolerance a recently discoveredpopulation of regulatory T-cells CD4+CD25+Foxp3+(Treg) plays an important role. These cells have potential in suppressingpathologic immune response observed in variousautoimmune diseases, including multiple sclerosis. In the presentwork, we showed reduction in the number and functionalactivity of Treg in peripheral blood of patients with multiple sclerosisin the acute stage, as well as increase in Treg content in thedisease remission and relation of the Treg content with durationof the autoimmune process and the degree of disability ofpatients.

Keywords